These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14534960)

  • 1. [Hepatotoxicity of antitubercular drugs. Apropos of 28 cases].
    Sakhri A; Ben Kemla S; Khadraoui M; Cheikh R
    Tunis Med; 2003 Jul; 81(7):488-94. PubMed ID: 14534960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
    Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
    Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatotoxicity of anti-tuberculosis chemotherapy in patients with liver cirrhosis.
    Shin HJ; Lee HS; Kim YI; Lim SC; Jung JP; Ko YC; Kwon YS
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):347-51. PubMed ID: 24670574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common risk factors for the development of anti tuberculosis treatment induced hepatotoxicity.
    Abbasi MA; Ahmed N; Suleman A; Zaman H; Tariq S; Anwar SA; Khan N
    J Ayub Med Coll Abbottabad; 2014; 26(3):384-8. PubMed ID: 25671954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early monitoring for detection of antituberculous drug-induced hepatotoxicity.
    Lee CM; Lee SS; Lee JM; Cho HC; Kim WS; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ
    Korean J Intern Med; 2016 Jan; 31(1):65-72. PubMed ID: 26767859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors.
    Shakya R; Rao BS; Shrestha B
    Ann Pharmacother; 2004 Jun; 38(6):1074-9. PubMed ID: 15122004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatotoxicity caused by antituberculosis drugs in pediatrics].
    Reto Valiente LV; Castillo Vergara J; Pichilingue Reto P; Pichilingue Prieto OA
    Rev Gastroenterol Peru; 2005; 25(4):362-5. PubMed ID: 16333392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary tuberculosis with chemotherapy related liver dysfunction].
    Yasuda K; Sato A; Chida K; Shichi I; Kishimoto H; Wada R; Tatsuta Y; Honda A; Yamazaki A
    Kekkaku; 1990 Jun; 65(6):407-13. PubMed ID: 2388450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampin hepatotoxicity associated with treatment of latent tuberculosis infection.
    Fountain FF; Tolley EA; Jacobs AR; Self TH
    Am J Med Sci; 2009 May; 337(5):317-20. PubMed ID: 19295414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of anti-tuberculous therapy-induced hepatotoxicity in patients and their outcome.
    Tariq S; Khan TS; Malik S; Anwar MS; Rashid A
    J Ayub Med Coll Abbottabad; 2009; 21(4):50-2. PubMed ID: 21067024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the concordance of results of determination of the activity of ornithine carbamoyltransferase, alanine transaminase and bilirubin in blood serum and the assessment of hepatic function in patients with pulmonary tuberculosis treated with drugs with special reference to hepatotoxic drugs].
    Pregowski W
    Gruzlica; 1973; 41(5):431-40. PubMed ID: 4710619
    [No Abstract]   [Full Text] [Related]  

  • 12. The management of anti-tuberculosis drug-induced hepatotoxicity.
    Tahaoğlu K; Ataç G; Sevim T; Tärün T; Yazicioğlu O; Horzum G; Gemci I; Ongel A; Kapakli N; Aksoy E
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):65-9. PubMed ID: 11263519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity.
    Fernández-Villar A; Sopeña B; Fernández-Villar J; Vázquez-Gallardo R; Ulloa F; Leiro V; Mosteiro M; Piñeiro L
    Int J Tuberc Lung Dis; 2004 Dec; 8(12):1499-505. PubMed ID: 15636498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of hepatotoxicity and antituberculosis therapy in South Carolina.
    Dowda M; Sy FS; Dowda H; Pozsik CJ
    J S C Med Assoc; 1998 Jan; 94(1):16-20. PubMed ID: 9473867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatotoxicity caused by glafenin. Apropos of 2 cases].
    Caballería Rovíra E; OFFso Ubeda RM; Arago López JV; Sanchís Closa A
    Rev Clin Esp; 1992 Jul; 191(3):166-8. PubMed ID: 1354388
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients.
    Ohkawa K; Hashiguchi M; Ohno K; Kiuchi C; Takahashi S; Kondo S; Echizen H; Ogata H
    Clin Pharmacol Ther; 2002 Aug; 72(2):220-6. PubMed ID: 12189369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ultrasonic examination of the liver in patients with pulmonary tuberculosis].
    Ivanov AK; Dzodzuashvili KA
    Klin Med (Mosk); 1990 Jan; 68(1):100-3. PubMed ID: 2186199
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic drug monitoring in patients exposed to antitubercular treatment].
    Domínguez JP; Amenábar E; Mendoza F; Pivet H; Palacios L; Lagos A; Diaz N; Calderón J; Cardenas R; Pérez-Olea J
    Rev Med Chil; 1982 Aug; 110(8):733-7. PubMed ID: 7156604
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-tubercular agent injuries to the liver in liver disease].
    Zhang P
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Nov; 21(11):643-4. PubMed ID: 11477886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.